Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
Workers' Comp
White Paper
ePay The Smart Way to Pay
Technology continues to be on the forefront of executives minds in the auto casualty and workers’ compensation industries.
Workers' Comp
Article
What Makes the Coventry Network Different Than Other Networks?
The Coventry Network is a national directly contracted workers’ compensation and auto network that has been investing in provider relationships for
Workers' Comp
News Release
Enlyte Honored with Two Stevie® Awards at 2023 American Business Awards®
Enlyte Leadership Team and Enlytened Trends Report Received Bronze and Gold Stevie® Awards for Excellence in Management and Publication
Mitchell
Case Study
How One Insurance Carrier Reduced Costs to Pay Medical Bills By 92%
Workers' Comp
White Paper
Guide to Selecting an Electronic Payments Vendor
On average, processing a paper provider check can cost claims organizations $8 per check.
Mitchell
News Release
Enlyte Releases Part 1 of Annual Pharmacy Solutions Drug Trends Report
Emerging trends include increases in retail and mail order prescriptions, high costs for topicals and migraine medications SAN DI